Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Times cited: 24
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Times cited: 8
Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
Times cited: 14